logo
Bombora and Simpli.fi Received Dick Reed Award for Channel Advancements and Innovation by Just Global

Bombora and Simpli.fi Received Dick Reed Award for Channel Advancements and Innovation by Just Global

Business Wire21-04-2025

NEW YORK--(BUSINESS WIRE)-- B ombora, a B2B data provider, has been awarded a Dick Reed Award for Channel Advancements & Innovation. This honor, also awarded to Simpli.fi, recognizes Bombora and Simpli.fi's first-to-market contextual targeting solution.
The Dick Reed Awards honor pioneers and innovators who are revolutionizing the B2B marketing landscape. Each year, the awards highlight leaders who demonstrate visionary thinking, strong partnerships, and impactful solutions that push the boundaries of what's possible in B2B marketing.
Bombora and Simpli.fi's first-to-market contextual targeting solution combines Bombora's patented Company Surge® Intent data with Simpli.fi's granular native targeting platform to allow B2B marketers to reach their target audiences in relevant ways, at the scale they need. This solution, derived from Bombora's one-of-a-kind Data Cooperative, gives advertisers access to more than 70 topic-oriented audience segments, including highly relevant topics like 'machine learning and artificial intelligence' and 'cryptocurrency'.
'Receiving the Dick Reed Award is further validation of our commitment to empower B2B marketing through data, insights, and strategic collaborations," said Mark Connon, CEO of Bombora. 'Our integration with Simpli.fi showcases how Bombora's B2B Intent data solution can unlock new opportunities and elevate results for brands and agencies to engage with the right audiences at the right time, across the right channels.'
About Bombora
The true B2B data pioneer, Bombora connects the B2B ecosystem in a one-of-a-kind Data Co-op of leading publishers, brand websites, and premium data providers. Leveraging advanced AI models, Bombora creates a holistic view of company research behavior enabling brands, agencies, and publishers to identify, understand, and reach their prospects and customers. Bombora provides a range of leading Intent, Identity, B2B Audiences and Campaign Measurement solutions, and makes them accessible within almost every B2B MarTech, RevTech, SalesTech and AdTech solution.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ASUS Announces Key Milestone with Nebius and Showcases NVIDIA GB300 NVL72 System at GTC Paris 2025
ASUS Announces Key Milestone with Nebius and Showcases NVIDIA GB300 NVL72 System at GTC Paris 2025

Associated Press

time17 minutes ago

  • Associated Press

ASUS Announces Key Milestone with Nebius and Showcases NVIDIA GB300 NVL72 System at GTC Paris 2025

Accelerating AI with scalable performance and next-gen infrastructure PARIS, June 11, 2025 /PRNewswire/ -- ASUS today joined GTC Paris at VivaTech 2025 as a Gold Sponsor, highlighting its latest portfolio of AI infrastructure solutions and reinforcing its commitment to advancing the AI Factory vision with a full range of NVIDIA® Blackwell Ultra solutions, delivering breakthrough performance from large-scale datacenter to personal desktop. ASUS is also excited to announce a transformative partnership milestone in its partnership with Nebius. Together, the two companies are enabling a new era of AI innovation built on NVIDIA's advanced platforms. Building on the success of the NVIDIA GB200 NVL72platform deployment, ASUS and Nebius are now moving forward with strategic collaborations featuring the next-generation NVIDIA GB300 NVL72 platform. This ongoing initiative underscores ASUS's role as a key enabler in AI infrastructure, committed to delivering scalable, high-performance solutions that help enterprises accelerate AI adoption and innovation. Andrey Korolenko, Chief Product and Infrastructure Officer at Nebius said: 'We have collaborated with ASUS for many years and appreciate its impressive capability to deliver swift and efficient solutions. ASUS not only delivers consistently against our exacting technical requirements, but also demonstrates deep professional expertise in building AI infrastructure. The company's forward-thinking approach and technical excellence have been a key enabler for our projects, and we look forward to working together to deliver the next generations of AI infrastructure.' AI servers: Building NVIDIA AI Factories for enterprise Leading the charge in AI advancement, ASUS is driving scalable, agentic AI through increased token generation. At GTC Paris, ASUS will unveil its latest AI Factory infrastructure solutions built on NVIDIA RTX PRO Servers as well as the NVIDIA Grace Blackwell Ultra systems. The ASUS AI POD,builtwiththeNVIDIA GB300 NVL72 system, delivers exceptional performance for complex AI inference tasks, making it ideal for advanced AI applications. Meanwhile, ASUS XA NB3I-E12, featuring the NVIDIAHGX B300 system, pushes the boundaries of AI computing with higher FLOPS and a massive 2.3TB of HBM3e memory — accelerating training and inference for large-scale models. To further address the growing demands of high-performance AI and HPC environments, ASUS introduced the new ESC8000A-E13P. This 4U NVIDIA MGX server supports up to eight NVIDIA RTX PRO6000 Blackwell Server Edition GPUs, NVIDIA BlueField-3 DPUs, and NVIDIA ConnectX-8SuperNICs with built-in PCIe® 6.0 switches, offering seamless integration, performance optimization, and scalability for modern data centers and agile IT deployments AI Inferencing: Enabling intelligent services at scale ASUS also unveiled powerful AI inference solutions, introducing a new lineup of workstations and a compact-sized supercomputer engineered to tackle today's most demanding workloads. Leading the range is the ExpertCenter Pro ET900N G3, the first system powered by the NVIDIA GB300 Grace Blackwell Ultra Superchip, with up to 784GB of large coherent memory. Another is the groundbreaking ASUS Ascent GX10, a compact AI supercomputer powered by the NVIDIA GB10 Grace Blackwell Superchip, that delivers 1,000 AI TOPS performance for demanding workloads. Equipped with a NVIDIABlackwell GPU, 20-core Arm CPU, and 128GB of memory, it supports AI models up to 200-billion parameters, placing petaflop-scale inferencing capabilities on developers' desks. Designed from the ground up for AI, both products deliver exceptional performance for large-scale training and inference on a desktop. Combined with the NVIDIA AIsoftwarestack, it is purpose-built for teams that demand the best in AI development. ASUS: Proven expertise in AI infrastructure With server expertise dating back to 1995, ASUS delivers reliable, end-to-end infrastructure solutions —ranging from individual components to fully integrated systems — backed by world-class R&D and global manufacturing capabilities. Driven by the Ubiquitous AI, Incredible Possibilities vision, ASUS supports clients in accelerating their advancement in the global AI race. Through flexible customization, deep technical expertise, and a proven track record in deployment, ASUS empowers enterprises to scale AI initiatives with confidence and efficiency. View original content to download multimedia: SOURCE ASUS

Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

Associated Press

time17 minutes ago

  • Associated Press

Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. 'We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC ™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,' said Howard Jonas, Chief Executive Officer, Executive Chairman and Chairman of the Board of Rafael Holdings. Mr. Jonas added, 'We have enhanced our financial position with the closing of a $25 million rights offering earlier this month which will support advancing this potential new treatment option for patients suffering from this rare genetic disease.' Rafael Holdings, Inc. Third Quarter Fiscal Year 2025 Financial Results As of April 30, 2025, we had cash and cash equivalents of $37.9 million. On June 4, 2025, the Company announced the closing of a $25 million rights offering, which, including the funding of the backstop commitment by the Jonas family, raised net proceeds of $24.9 million after deduction of certain expenses incurred in connection with the offering. For the three months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $4.8 million, or $0.19 per share, versus a net loss of $32.4 million, or $1.36 per share in the year ago period. The year over year decrease in net loss is attributable to non-cash items, primarily unrealized losses of $1.4 million on the Company's investment in Cyclo equity which we purchased in advance of the potential merger in the current period versus $4.4 million in the year ago period, combined with an in-process R&D expense of $89.9 million related to the acquisition of Cornerstone, partially offset by a $31.3 million recovery of receivables from Cornerstone in the year ago period. Research and development expenses were $3.0 million for the three months ended April 30, 2025, compared to $1.5 million in the year ago period. The year over year increase relates to the inclusion in the current year period of spending at Cyclo Therapeutics following the March 25, 2025 merger and the activity of Cornerstone and Day Three which were consolidated with Rafael Holdings during fiscal 2024. General and administrative expenses were $3.2 million for the three months ended April 30, 2025, compared to $1.9 million in the year ago period. The year over year increase relates to the inclusion of Cyclo Therapeutics following closing of the merger, and the activity of Cornerstone and Day Three, following their consolidation. Rafael Holdings, Inc. First Nine Months Fiscal Year 2025 Financial Results For the nine months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $18.4 million, or $0.73 per share, versus a net loss of $29.9 million, or $1.26 per share in the year ago period. The year over year decrease in net loss is attributable to in-process R&D expense of $89.9 million related to the acquisition of Cornerstone net with a $31.3 million recovery of receivables from Cornerstone in the year ago period and $3.2 million in unrealized gains on the Company's investment in Cyclo equity. Research and development expenses were $5.3 million for the nine months ended April 30, 2025, compared to $2.6 million in the year ago period. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. For the nine months ended April 30, 2025, general and administrative expenses were $8.3 million compared to $6.5 million in the same period in the prior year. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. About Rafael Holdings, Inc. Rafael Holdings, Inc. holds interests in clinical and early-stage pharmaceutical and certain other companies, including our wholly owned subsidiary, Cyclo Therapeutics, LLC, a clinical stage biotechnology company dedicated to developing Rafael's lead clinical candidate, Trappsol® Cyclo™, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 ('NPC1'), a rare, fatal, and progressive genetic disorder. Rafael also holds majority equity interests in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their existing cannabis offerings. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended July 31, 2024, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact: Barbara Ryan [email protected] (203) 274-2825

OTC Markets Group Welcomes DIRTT Environmental Solutions Ltd to OTCQX
OTC Markets Group Welcomes DIRTT Environmental Solutions Ltd to OTCQX

Hamilton Spectator

time24 minutes ago

  • Hamilton Spectator

OTC Markets Group Welcomes DIRTT Environmental Solutions Ltd to OTCQX

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DIRTT Environmental Solutions Ltd (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, has qualified to trade on the OTCQX® Best Market. DIRTT Environmental Solutions Ltd upgraded to OTCQX from the Pink® market. DIRTT Environmental Solutions Ltd begins trading today on OTCQX under the symbol 'DRTTF.' U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. About DIRTT Environmental Solutions Ltd DIRTT is a leader in industrialized construction. DIRTT's system of physical products and digital tools empowers organizations, together with construction and design leaders, to build high-performing, adaptable, interior environments. Operating in the workplace, healthcare, education, and public sector markets, DIRTT's system provides total design freedom, and greater certainty in cost, schedule, and outcomes. DIRTT's interior construction solutions are designed to be highly flexible and adaptable, enabling organizations to easily reconfigure their spaces as their needs evolve. About OTC Markets Group Inc. OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market, and Pink® Open Market. Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets. OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATSTM are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC. To learn more about how we create better informed and more efficient markets, visit . Subscribe to the OTC Markets RSS Feed Media Contact: OTC Markets Group Inc., +1 (212) 896-4428, media@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store